MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Effervescent tablets and packaging contains desiccant.

Provenance

This compatibility recommendation is derived from Adcal-D3 Dissolve 1500mg/400unit effervescent tablets (Kyowa Kirin Ltd).

Stability Notes

Protect from moisture.

Provenance

This compatibility recommendation is derived from Cholestagel 625mg tablets (Neon Healthcare Ltd).

Stability Notes

Protect from moisture.

Provenance

This compatibility recommendation is derived from Cholestagel 625mg tablets (Neon Healthcare Ltd).

Stability Notes

Protect from moisture.

Provenance

This compatibility recommendation is derived from Cholestagel 625mg tablets (Neon Healthcare Ltd).

Stability Notes

Protect from moisture.

Provenance

This compatibility recommendation is derived from Cholestagel 625mg tablets (Neon Healthcare Ltd).

Stability Notes

Protect from moisture.

Provenance

This compatibility recommendation is derived from Cholestagel 625mg tablets (Neon Healthcare Ltd).

Stability Notes

There are no stability notes available for this medicine.

Stability Notes

Store in well-filled airtight containers, protect from light.

Provenance

This compatibility recommendation is derived from Fultium-D3 800unit capsules (Internis Pharmaceuticals Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.